Breakthroughs
Breakthroughs
Pfizer
Meeting the challenge of Antimicrobial Resistance (AMR)
36 minutes Posted May 10, 2023 at 11:00 am.
0:00
36:13
Download MP3
Show notes

Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK, to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.

 

PP-UNP-GBR-4716 / May 2023